GLYCOGEN STORAGE DISEASE TYPE IB
Clinical trials for GLYCOGEN STORAGE DISEASE TYPE IB explained in plain language.
Never miss a new study
Get alerted when new GLYCOGEN STORAGE DISEASE TYPE IB trials appear
Sign up with your email to follow new studies for GLYCOGEN STORAGE DISEASE TYPE IB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drug shows promise for rare immune disorder
Disease control TerminatedThis phase 2 trial tests whether empagliflozin, a diabetes drug also known as Jardiance, can help people with glycogen storage disease type Ib (GSD-1b). GSD-1b causes low neutrophil counts, leading to frequent infections and bowel inflammation. The study gives empagliflozin orall…
Matched conditions: GLYCOGEN STORAGE DISEASE TYPE IB
Phase: PHASE2 • Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Newborn screening study aims to catch rare diseases at birth
Diagnosis OngoingThis study offers voluntary screening for newborns in North Carolina to detect a wide range of rare health conditions early. Using a small blood sample already collected at birth, the program tests for dozens of disorders, including spinal muscular atrophy, cystic fibrosis, and m…
Matched conditions: GLYCOGEN STORAGE DISEASE TYPE IB
Sponsor: RTI International • Aim: Diagnosis
Last updated Jul 02, 2026 03:00 UTC